| 4BIO Capital |
| 4BIO Capital |
| Abingworth LLP |
| Ablatus Therapeutics Limited |
| Ablatus Therapeutics Limited |
| ABPI |
| Abreos Biosciences |
| Accelerace |
| Accelmed |
| Accequa |
| Accunea Ltd |
| Acticor Biotech |
| Advent Life Sciences |
| Advent Life Sciences |
| Advent Life Sciences |
| Aerogen |
| Affiris AG |
| AIM Targeted Therapies |
| Alacrita |
| Alacrita |
| Albion Technology & General VCT plc |
| AlbionVC |
| Alira Health |
| Allen & Overy LLP |
| Allen & Overy LLP |
| Alsa Holdings |
| ALSA Holdings Ltd |
| Amadeus Capital |
| AMRA Medical |
| Andera Partners |
| Angel Investor |
| Angel Investor |
| Angel Investor |
| Angel Investor |
| Anima Biotech Inc |
| ANTABIO SAS |
| ANTABIO SAS |
| AorticLab |
| Apollo Ventures |
| Apollo Ventures |
| Apollo Ventures |
| Apollo Ventures |
| Apollo Ventures |
| Appleyard Lees IP LLP |
| Arctoris |
| Arecor Limited |
| Arecor Limited |
| Areterial Capital Management |
| Argenx |
| ARGO Publishing GmbH |
| Arix Bioscience PLC |
| Arix Bioscience PLC |
| Arix Bioscience PLC |
| Arix Bioscience PLC |
| Arix Bioscience PLC |
| Arix Bioscience PLC |
| Arterial Capital Management |
| Arterius Limited |
| Arthurian Life Sciences |
| Asabys Partners |
| Askel Healthcare |
| Astellas Pharma Europe Ltd |
| AstraZeneca |
| AstraZeneca |
| Atlantic Healthcare |
| Atriva Therapeutics GmbH |
| Atriva Therapeutics GmbH |
| AudioCure Pharma GmbH |
| AudioCure Pharma GmbH |
| AuXin Surgery |
| Axalbion |
| Axon Capital Partners |
| Azadyne Ltd |
| Balmes Transplantation |
| Barclays |
| Barclays |
| Barcode Diagnostics |
| Bayer |
| Bayer AG |
| BB Pureos Bioventures |
| BBN Cardio Therapeutics BV |
| BCMG AG |
| Belsize Asset Management |
| BenevolentAI |
| BGV |
| BioCity |
| BioCubaFarma |
| BioCubaFarma |
| BioCubaFarma |
| Bionest Partners Finance |
| BioNTech AG |
| BioNTech AG |
| Bioscience Managers |
| Bioscience Managers |
| BioSeed Capital |
| BioStock |
| BioStock |
| Biotissue SA |
| Bird&Bird |
| Bird&Bird |
| Black Belt Therapeutics |
| Blenheim AI Health |
| Bloomberg |
| Bluebee Holding BV |
| BlueOcean Ventures SA |
| BNP Paribas Asset Management |
| Boehringer Ingelheim |
| Bond Asian Ventures Limited |
| Boston Scientific |
| Boston Scientific |
| BrainPatch |
| Breed Reply |
| Bridge Biotec Ltd |
| Bridge Valley Ventures |
| Bridge Valley Ventures |
| Bridge Valley Ventures |
| Bridge Valley Ventures |
| British Embassy in Havana Cuba |
| BROTHERS & PARTNERS EUROPE |
| Brunswick |
| Bryan, Garnier & Co |
| Bryan, Garnier & Co |
| BunyaVax |
| Cagen Ltd |
| CALCIVIS |
| Cambridge Innovation Capital |
| Cambridge Innovation Capital plc |
| Cambridge Oncometrix Ltd |
| Cancer Research UK |
| Capital Family Office |
| Capricorn Venture Partners |
| CareChain AB |
| Cascara Ventures Bvba |
| Cascara Ventures Bvba |
| Catapult Ventures |
| Catapult Ventures |
| Causaly Inc |
| Causaly Inc |
| CeiROx Life Sciences SA |
| Celixir Plc |
| Cellnovo Ltd |
| Cellply S.r.l. |
| Cellply Srl |
| Chamber of Commerce, Cuba. |
| Charles River |
| Choose New Jersey |
| Choose New Jersey |
| Chronolife |
| Chronolife |
| Citi |
| Citi |
| Clinical Design Technologies Ltd |
| CLS AB |
| CLS AB |
| Clubb Capital Ltd |
| CMR Surgical |
| CMS Cameron McKenna Nabarro Olswang LLP |
| CMS Cameron McKenna Nabarro Olswang LLP |
| CMS Cameron McKenna Nabarro Olswang LLP |
| CMS Cameron McKenna Nabarro Olswang LLP |
| CMS Cameron McKenna Nabarro Olswang LLP |
| CN Bio Innovations Ltd |
| CN Bio Innovations Ltd |
| Coalesce |
| Cognetivity Neurosciences |
| Cole Capital Consultancy Ltd |
| Colpman Consulting |
| COMPASS Pathways |
| COMPASS Pathways |
| COMPASS Pathways |
| CONAVI MEDICAL INC. |
| Consilium Strategic Communications |
| Consilium Strategic Communications |
| Consultant |
| CorWave |
| Coulter Partners |
| Covington & Burling LLP |
| Covington & Burling LLP |
| Covington & Burling LLP |
| Covington & Burling LLP |
| Covington & Burling LLP |
| Covington & Burling LLP |
| CrystalsFirst GmbH |
| CureVac AG |
| DataArt |
| DataArt |
| Daten Capital LLP |
| DeBere Capital Partners |
| DeBere Capital Partners |
| Deeprbridge Capital LLP |
| Deeprbridge Capital LLP |
| Deltec Bank |
| Deltec Bank |
| Deltec Bank |
| Desktop Genetics |
| Destiny Pharma PLC |
| Deutsche Bank AG London |
| DiamedCare |
| DiaMedCare AG |
| DN Capital |
| Dovetail Lab |
| Downing LLP |
| Downing LLP |
| drfocused (Medic Passport) |
| Droia |
| Dyadic International Inc., |
| e-Therapeutics plc |
| e-Therapeutics plc |
| Eabha Investments |
| Earlybird Venture Capital |
| EATRIS |
| Edison Investment Research |
| EIO Biomedical Ltd. |
| Elevian, Inc. |
| Eli Lilly & Company |
| Eli Lilly & Company |
| Eli Lilly & Company |
| Eli Lilly & Company |
| Eli Lilly & Company |
| Eli Lilly & Company |
| Elitename |
| Embleema Inc. |
| EMV Capital Ltd |
| EMV Capital Ltd |
| Endeavour Vision |
| Endodiag |
| Endodiag |
| EndoGI Medical |
| Endovascular Development AB |
| Enterprise Ireland |
| Envoy Biosciences |
| Epidarex Capital |
| Epidarex Capital |
| Epidarex Capital |
| EpiEndo Pharmaceuticals |
| EpiEndo Pharmaceuticals |
| EpimAb Biotherapeutics |
| Episode1 Ventures |
| Ergomed plc |
| ESP Technology |
| ESP Technology |
| Esperante |
| Eternans |
| Eucardia S.r.l. |
| Evox Therapeutics |
| Excite Capital Partners LLP |
| Excite Capital Partners LLP |
| F-Prime Capital |
| FarmaTrust |
| Financial Times |
| FIRE1 |
| FIRE1 |
| firstminute capital |
| FirstWord |
| FLOWSION A/S |
| FMV First Momentum Ventures Management GmbH |
| Forbion |
| Former MP, EP & UK Health Minister |
| FreeMind Group |
| Fresenius Medical Care |
| Freshfields Bruckhaus Deringer LLP |
| Freshfields Bruckhaus Deringer LLP |
| Freshfields Bruckhaus Deringer LLP |
| FTI Consulting |
| FTI Consulting |
| Future Care Capital |
| Future Health Collective |
| GeneQuine Biotherapeutics GmbH |
| Genomes.io |
| Genomes.io |
| Genosis |
| Gideon Barak |
| Gilde healthcare |
| Gill Jennings & Every |
| Gill Jennings & Every |
| Gill Jennings & Every |
| Gill Jennings & Every |
| Gimv |
| GL Capital |
| Global Core Medical |
| GlobalData plc |
| GlycoSeLect Ltd |
| Goldman Sachs |
| Goodwin |
| Goodwin |
| Goodwin |
| Goodwin |
| GreenBone Ortho srl |
| GSK |
| GTX medical B.V. |
| GTX medical B.V. |
| Guided Solutions |
| Guided Solutions |
| GyreOx |
| Hadean Ventures |
| Haoma Medica |
| Harbert European Growth Capital |
| HBM Partners AG |
| HBM Partners AG |
| Head Diagnostics Ltd |
| Health Equity Consulting Ltd |
| Healthcare for Humanity |
| HealthCare Royalty Partners |
| Healthcor Management |
| Hermes Partners Intl. Ltd. |
| High-Tech Gründerfonds |
| High-Tech Gründerfonds |
| HiMed Angel Fund |
| Hong Kong Science and Technology Parks Corporation |
| Horizon Discovery |
| Horton International Global Healthcare |
| HOX Therapeutics Ltd |
| HOX Therapeutics Ltd |
| hVivo |
| hVivo |
| IBM |
| Ignite Capital Partners, Inc |
| Illumina |
| Illumina |
| Illumina |
| illumina |
| imec.xpand |
| IMM-Research |
| IMM-Research |
| IMM-Research |
| Immatics US |
| Immunicum AB |
| ImmuPharma plc |
| Imperial City Angels |
| Imperial Innovations |
| Imperial Innovations |
| IMT Innovation |
| In Vivo - Informa Pharma Intelligence |
| Inceptua Group |
| Inceptua Group |
| Independent |
| Industrial Ventures |
| Industrifonden |
| Informa |
| Informa |
| InHealth Ventures |
| Inivata |
| Inkef Capital BV |
| Inkef Capital BV |
| Innovate UK |
| Innovate UK |
| Innovate UK |
| Innovative Immunotherapy Alliance |
| Innovative Immunotherapy Alliance |
| INOTREM |
| Inserm Transfert |
| Insightra Medical |
| Instinctif Partners |
| InteRNA Technologies BV |
| Inventages |
| Invest Newcastle |
| Invizius |
| IP Group |
| IP Group |
| IPF Partners |
| Ipsen |
| IQVIA (legacy Quintiles & IMS Health) |
| ISA Pharmaceuticals BV |
| Javelin Orthopaedics |
| Johnson & Johnson Innovation - JJDC |
| Johnson & Johnson Innovation - JJDC |
| Johnson & Johnson Innovation - JJDC |
| Johnson & Johnson Innovation - JJDC |
| Johnson & Johnson Innovation - JJDC |
| Johnson & Johnson Innovation - JJDC |
| Johnson & Johnson Innovation - JJDC |
| Joint Polish Investment Fund |
| Jolt Capital |
| Julz Co LLC |
| Juvenescence |
| KBC Securities |
| Kempen |
| King's College London |
| King's College London |
| Kissei America |
| Kreos Capital |
| Kreos Capital |
| Kreos Capital |
| Kurma Partners |
| Kurma Partners |
| Latham & Watkins |
| Latham & Watkins |
| Latham & Watkins |
| Lavendr Project, Ricolab |
| leon-nanodrugs GmbH |
| leon-nanodrugs GmbH |
| Life Biosciences |
| Life Biosciences |
| LifeArc |
| LifeArc |
| LifeArc |
| LifeArc |
| Lifebit |
| LIG Biowise |
| LIG Biowise |
| Lightpoint Medical |
| Lightstone Ventures |
| LimFlow SA |
| LimmaTech Biologics AG |
| LimmaTech Biologics AG |
| LivaNova |
| Livzon investment group |
| Locate Bio Ltd |
| Longitude Capital |
| Longwall Ventures |
| Lonza |
| LSP |
| LSP |
| LSX |
| LSX |
| LSX |
| LSX |
| LSX |
| LSX |
| LSX |
| LSX |
| LSX |
| LU Innovation, Lund University |
| LU Innovation, Lund University |
| Luminous Ventures |
| Luminous Ventures |
| Luminous Ventures |
| Luminous Ventures |
| Lundbeckfonden Emerge |
| Lytix Biopharma AS |
| Lytix Biopharma AS |
| Malin Corporation plc |
| Marks & Clerk |
| Marks & Clerk |
| Marks & Clerk |
| Marks & Clerk |
| Matheson |
| Medherant |
| Medherant |
| Medicalchain |
| Medicalchain |
| Medicxi |
| Medimmune |
| Medimmune |
| MediSieve Limited |
| Mednous |
| Medopad |
| Medovate Ltd |
| Medtech Insight, Informa Business Intelligence |
| Medtech Insight, Informa Business Intelligence |
| Medtronic International |
| Medtronic International |
| MedVASC |
| Melanie Senior |
| Meneldor |
| Mercia Technologies |
| Mercia Technologies |
| Mercia Technologies |
| Merck KGaA |
| Merck Serono |
| Merck Ventures B.V. |
| Merck Ventures B.V. |
| Merck Ventures B.V. |
| Merck Ventures B.V. |
| Merck Ventures B.V. |
| Merck Ventures B.V. |
| Merck Ventures B.V. |
| Merger Market |
| Meridian Bioscience |
| Metys Pharmaceuticals Ltd. |
| miDiagnostics nv |
| miDiagnostics nv |
| Miracor Medical |
| Mission Therapeutics |
| Mission Therapeutics |
| Mitotech S.A. |
| Mitotech S.A. |
| Momentum Biotech |
| MSD |
| MSD |
| MTIP |
| MTIP |
| MVM Partners LLP |
| N4 Pharma Plc |
| NANOGAP Therapeutics |
| Nanoligent SL |
| Nasdaq |
| Nasdaq |
| Nasdaq |
| Nature Biotechnology |
| NatureVolve |
| NCL Technology Ventures Ltd |
| NCL Technology Ventures Ltd |
| NCL Technology Ventures Ltd |
| NCL Technology Ventures Ltd |
| NDA Group |
| NDA Group |
| NeoMed |
| Netherlands Foreign Investment Agency |
| NetScientific |
| Neuroresolving therapeutics |
| Neurxstem Inc |
| New Rhein Healthcare Investors |
| New Science Fund |
| Newable Private Investment |
| Newable Private Investment |
| Newstar Ventures |
| NFIA UK |
| NGT3 VC |
| Nigel Pitchford |
| Nightingale Health |
| NMD Pharma |
| Norgine Ventures |
| Norgine Ventures |
| Norgine Ventures |
| Norgine Ventures |
| North-East Healthcare Investment |
| Novartis |
| Novartis |
| Novartis |
| Novo Holdings A/S |
| Novo Nordisk |
| Novo Ventures |
| Novo Ventures |
| NSF International |
| NSF International |
| NSF International |
| Nuformix |
| Nuritas Limited |
| NVM Private Equity LLP |
| NY Consulting AB |
| o2h |
| Octopus Apollo VCT |
| Oisin Biotech |
| Oncorena |
| Oost NL |
| OostNL |
| Optellum Ltd |
| Optimum Strategic Communications |
| Optimum Strategic Communications |
| Optimum Strategic Communications |
| Orbimed |
| Orbit Discovery |
| Orbit Discovery |
| Orexo AB |
| Otsuka Pharmaceuticals |
| Oxehealth |
| Oxford BioMedica |
| Oxford BioMedica |
| Oxford Cardiomox Ltd |
| Oxford Endovascular Ltd |
| Oxford Medical Implants |
| Oxford Technology Management |
| Oxford University Innovation |
| Oxford University Innovation |
| Oxford VR |
| Oxon |
| Panacea Venture |
| Panakes Partners |
| Panmure Gordon |
| Pathfinder Medical |
| Peppermint Venture Partners |
| perora GmbH |
| Pfizer |
| Pfizer |
| PhagoMed Biopharma GmbH |
| Pharma Intelligence |
| Pharma Publications |
| Pharma Ventures |
| Pharma Ventures |
| Pharmstandard Ventures |
| Philips Health Technology Ventures |
| Philips Innovation Services |
| Philips Innovation Services |
| PKvitality |
| Polar Capital |
| Poltreg |
| Poltreg |
| PPD |
| PreciHealth |
| Premier Research |
| Primex Pharmaceuitcals |
| ProClinical Executive |
| Protembis GmbH |
| Protembis GmbH |
| Proteon Pharmaceuticals S.A. |
| Prudential Financial |
| Pureos Bioventures |
| Q3 Medical Devices Ltd |
| Quanta Dialysis Technologies Ltd |
| Quanta Dialysis Technologies Ltd |
| QuantuMDx |
| Questra Alternative Asset Managers |
| RBV Capital |
| Redalpine Venture Partners |
| ReNeuron Group plc |
| ReNeuron Group plc |
| Renovos Biologics |
| Respiratorius AB |
| RMI Partners |
| Robocath |
| Roche |
| Roche |
| Rosetta Capital Ltd |
| Rowanalytics |
| RowAnalytics Ltd |
| RSA Consulting |
| RSA Consulting |
| Ruffena Capital Ltd |
| SAGA Diagnostics |
| SageTech Medical Equipment |
| Sanara Ventures |
| Sanderson Asset Management |
| Saniona |
| Saniona |
| Sanofi |
| Sanofi Ventures |
| SBI JI Innovation Fund |
| Scancell |
| Schuh Langmeier e.K. / OrmoSys |
| Sciad Communications |
| Sciad Communications |
| SDS Optic |
| Securecell AG |
| Sensyne Health |
| Sensyne Health |
| Seroba Life Sciences |
| Seventure |
| Shanghai Innovation Investment Company |
| Shield Therapeutics |
| Shield Therapeutics |
| Shivom |
| SHS Capital |
| Siemens Healthineers |
| Silicon Valley Bank |
| Silicon Valley Bank |
| Simbec Orion Group |
| Simcere Pharmaceutical Group |
| Sixth Element Capital |
| SJB Technical Recruitment Ltd |
| Sofinnova Partners |
| Sofinnova Partners |
| Sofinnova Partners |
| Sofinnova Partners |
| Sosei Heptares |
| SOSV |
| sp2 Consulting Limited |
| SPARK Impact |
| SR One |
| Staatz Business Development & Strategy |
| Start Codon Limited |
| Start Codon Limited |
| Start Codon Limited |
| Stayble Therapeutics AB |
| Stifel |
| Stoerseth Holding Ltd |
| Storm Therapeutics |
| SVB Leerink |
| SVBLeerink |
| Swedbank Robur |
| Syncona Investment Management Ltd |
| Syncona Investment Management Ltd |
| Syncona Investment Management Ltd |
| Syneos Health |
| Synergia Medical SA |
| Syngene International Ltd |
| Syngene International Ltd |
| Taiho Ventures |
| Takeda |
| Takeda Ventures, Inc. |
| TalentMark |
| TargEDys |
| Temasek |
| Temasek |
| TETRANEURON, S.L. |
| TETRANEURON, S.L. |
| Teva |
| Teva |
| The Braff Group |
| Tibbiyah Holdings |
| Trillium Medical Ventures |
| Trinity Delta |
| Trinity Delta |
| Trinity Delta |
| Trinity Research & Innovation Trinity College Dublin |
| Truffle Capital |
| truu |
| Tuspark UK |
| TusPark UK |
| TVM Life Science Management |
| UCB Pharma |
| UCB Pharma |
| UCB Pharma |
| UCB Ventures |
| UCB Ventures |
| UCB Ventures |
| UCL Technology Fund (AlbionVC) |
| UKI2S |
| Unblocked |
| UNION therapeutics A/S |
| UNION therapeutics A/S |
| Unite Genomics |
| Unite Genomics |
| Universitat Autònoma de Barcelona |
| Upopa |
| Uromems |
| UROMEMS |
| UTILITY therapeutics Ltd |
| UVM Health Network Ventures Inc. |
| UVM Health Network Ventures Inc. |
| Vagus Health Ltd. |
| Valo Therapeutics Ltd |
| Vantage |
| Vantage |
| Vantage |
| Various |
| Vascular Graft Solutions.com |
| Ventac Partners |
| Ventac Partners |
| Ventac Partners |
| Verdict Network |
| Verona Pharma plc |
| Verona Pharma plc |
| Versantis AG |
| WG Partners LLP |
| Wharton Asset Management |
| White & Case LLP |
| White & Case LLP |
| White & Case LLP |
| White & Case LLP |
| WuXi AppTec |
| Xeraya Capital |
| Xintela AB |
| Xintela AB |
| Xplico |
| Ypsomed AG |
| Zcube - Zambon research venture |
| Zilia |
| Zilico Limited |
